113 related articles for article (PubMed ID: 37788370)
1. LINC00707 promotes multidrug resistance of ovarian cancer cells by targeting the miR-382-5p/LRRK2 axis.
Zhao MW; Lin CJ; Qiu JP
Acta Biochim Pol; 2023 Oct; 70(4):799-806. PubMed ID: 37788370
[TBL] [Abstract][Full Text] [Related]
2. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1.
Zhuang L; Zhang B; Liu X; Lin L; Wang L; Hong Z; Chen J
Cell Biol Int; 2021 Oct; 45(10):2140-2149. PubMed ID: 34288231
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PRNCR1 promotes ovarian cancer cell proliferation, migration and invasion by targeting the miR-653-5p/ELF2 axis.
Qi X; Chen D; Yu W; Wang L; Liu L; Tao X
Mol Cell Biochem; 2022 May; 477(5):1463-1475. PubMed ID: 35166984
[TBL] [Abstract][Full Text] [Related]
5. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
6. LncRNA CRNDE promotes cell proliferation, migration and invasion of ovarian cancer via miR-423-5p/FSCN1 axis.
Wang Q; Wang LX; Zhang CY; Bai N; Feng C; Zhang ZM; Wang L; Gao ZZ
Mol Cell Biochem; 2022 May; 477(5):1477-1488. PubMed ID: 35166986
[TBL] [Abstract][Full Text] [Related]
7. LINC00707 Promotes Cell Proliferation in Cervical Cancer via the miR-374c-5p/SDC4 Axis.
Fang F; Guo C; Zheng W; Li Q
Biomed Res Int; 2022; 2022():5793912. PubMed ID: 35937409
[TBL] [Abstract][Full Text] [Related]
8. The Long Intergenic Noncoding RNA 00707 Sponges MicroRNA-613 (miR-613) to Promote Proliferation and Invasion of Gliomas.
Liu H; Hu K
Technol Cancer Res Treat; 2020; 19():1533033820962092. PubMed ID: 33107401
[TBL] [Abstract][Full Text] [Related]
9. MiR-590-5p promotes cisplatin resistance via targeting hMSH2 in ovarian cancer.
Li B; Xu X; Zheng L; Jiang X; Lin J; Zhang G
Mol Biol Rep; 2023 Aug; 50(8):6819-6827. PubMed ID: 37392283
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of lncRNA LINC00707 alleviates LPS-induced injury in MRC-5 cells by acting as a ceRNA of miR-223-5p.
Zou X; Gao C; Shang R; Chen H; Wang B
Biosci Biotechnol Biochem; 2021 Feb; 85(2):315-323. PubMed ID: 33604647
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
Zheng X; Zhou Y; Chen W; Chen L; Lu J; He F; Li X; Zhao L
Cell Physiol Biochem; 2018; 51(3):1340-1353. PubMed ID: 30481782
[TBL] [Abstract][Full Text] [Related]
12. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
[No Abstract] [Full Text] [Related]
13. Long noncoding RNA LINC00858 promotes the progression of ovarian cancer via regulating the miR-134-5p/TRIM44 axis.
Li P; Huang G
J Recept Signal Transduct Res; 2022 Aug; 42(4):382-389. PubMed ID: 34423728
[TBL] [Abstract][Full Text] [Related]
14. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p.
Zhao Y; Yuan D; Zhu D; Xu T; Huang A; Jiang L; Liu C; Qian H; Bu X
J Ovarian Res; 2021 Aug; 14(1):109. PubMed ID: 34454554
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
Shen Y; Lv M; Fang Y; Lu J; Wu Y
J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop.
Gao T; Ji Y
Urol Int; 2021; 105(9-10):891-905. PubMed ID: 34192702
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TTN-AS1 acts as sponge for miR-15b-5p to regulate FBXW7 expression in ovarian cancer.
Miao S; Wang J; Xuan L; Liu X
Biofactors; 2020 Jul; 46(4):600-607. PubMed ID: 32049388
[TBL] [Abstract][Full Text] [Related]
20. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]